By G HossainPosted on October 30, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Alnylam shares dropped by a quarter on Thursday, with analysts suggesting the decline puts the RNAi specialist within range for a takeout. ‘We need to do better,’ Alnylam CEO admits, as uncertainty looms over transthyretin franchise Post navigation New biotech Setara forms with $90M to take on Jazz’s bonus rare disease programsSanofi targets late-phase and commercial M&A to offset looming Dupixent decline
